5-HT system and cognition

Neuroscience and Biobehavioral Reviews

Volumn 23, Issue 8, 1999, Pages 1111-1125

  Meneses, A ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

5 HT receptors; Consolidation; Learning; Memory; Serotonin

Indexed keywords

1 (2 METHOXYPHENYL) 4 (4 PHTHALIMIDOBUTYL)PIPERAZINE; 2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 4 DIPROPYLAMINO 1,3,4,5 TETRAHYDROBENZ[CD]INDOLE 6 CARBOXAMIDE; 8 [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] 8 AZASPIRO[4.5]DECANE 7,9 DIONE; BUSPIRONE; FLESINOXAN; GEPIRONE; IPSAPIRONE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; N TERT BUTYL 3 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL] 2 PHENYLPROPIONAMIDE; POSTSYNAPTIC RECEPTOR; PRESYNAPTIC RECEPTOR; SEROTONIN; SEROTONIN 1A RECEPTOR; SEROTONIN 1B RECEPTOR; SEROTONIN 2A RECEPTOR; SEROTONIN 2B RECEPTOR; SEROTONIN 2C RECEPTOR; SEROTONIN 3 RECEPTOR; SEROTONIN 4 RECEPTOR; SEROTONIN 7 RECEPTOR; TANDOSPIRONE; XALIPRODEN;

BRAIN FUNCTION; BRAIN REGION; COGNITION; DRUG RECEPTOR BINDING; LEARNING DISORDER; MEMORY; PRIORITY JOURNAL; REVIEW; SEROTONINERGIC SYSTEM; SEROTONINERGIC TRANSMISSION;

ANIMALS; BRAIN CHEMISTRY; COGNITION; HUMANS; RECEPTORS, SEROTONIN; SEROTONIN; SEROTONIN AGENTS;

EID: 0032716595     PISSN: 01497634     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0149-7634(99)00067-6     Document Type: Review

References (188)

1. Aghajanian G.K., Andrade R. Electrophysiology of 5-HT receptors. Baumgarten H.G., Gother M. Serotoninergic neurons and 5-HT receptors in the CNS. 1997;499-535 Springer, Berlin.
2. Albrecht D., Stein C., Pollandt S. Dual effects of the 5-HT1A receptor stimulation on neuronal firing rate in the basolateral amygdala can be explained by the involvement of interneurones. Soc Neurosci Abstr. 24:1998;1366.
3. Amaral D.G., Dolorfo C., Alvarez-Royo P. Organization of CA1 projections to the subiculum: a PHA-L analysis in the rat. Hippocampus. 1:1991;415-436.
4. Aloyo V.J., Hoffman M.E., Harvey J.A. Evidence for inverse agonism at the native 5-HT2A receptor. Soc Neurosci Abstr. 24:1998;1097.
5. Altman H.J., Normile H.J. What is the nature of the role of the serotonergic nervous system in learning and memory? prospects for development of an effective treatment strategy for senile dementia. Neurobiol Aging. 9:1988;627-638.
6. Arnsten A.F.T, van Dyck C.H. Monoamines and acetylcholine influences on higher cognitive functions in nonhuman primates: relevance of the treatment of Alzheimer's disease. Brioni J.D., Decker M.W. Neuropathology and functional anatomy of Alzheimer's disease: pharmacological treatment of Alzheimer's disease. 1997;63-86 Wiley-Liss, New York.
7. Azmitia E.C., Whitaker-Azmitia P. Development and adult plasticity of serotoninergic neurons and their target cells. Baumgarten H.G., Gother M. Serotoninergic neurons and 5-HT receptors in the CNS. 1997;1-39 Springer, Berlin.
8. Bartolomeo A.C., Morris H., Moyer J.A., Boast C.A. Attenuated MK-801-induced impairment of radial maze performance in rats: a possible model predicting efficacy in Alzheimer's disease. Soc Neurosci Abstr. 22:1996;143.
9. 2 receptor subtypes: a family re-united? TIPS. 16:1996;105-110.
10. Bergis O.E., Moser P.C., Santamaria R., Schoemaker H., Oblin A., Lochead A.W., Jegham S., Sanger D.J., George P. SL65.0102, a novel and selective partial agonist at 5-HT4 receptors, improves learning and memory in rodents. Soc Neurosci Abstr. 24:1998;2124.
11. Blier P., Lista A., De Monigny C. Differential properties of pre- and postsynaptic 5-hydroxytryptamine1A receptors in the dorsal raphe and hippocampus. 1. Effect of spiperone. J Pharmacol Exp Theor. 265:1993;7-15.
12. Bockaert J., Claeyen S., Dumuis A. Molecular biology, function and pharmacological role of 5-HT4 receptors. Naunyn-Schmiedeber's Arch Pharmacol. 358:1998;R10. Suppl 1.
13. Buhot M.C. Serotonin receptors in cognitive behaviors. Curr Opin Neurobiol. 7:1997;243-254.
14. Carli M., Samanin R. 8-Hydroxy-2- (di-n-propylamino) tetralin impairs spatial learning in a water maze: role of postsynaptic 5-HT1A. Br J Pharmacol. 105:1992;720-726.
15. Carli M., Luschi R., Garofalo P., Samanin R. 8-OH-DPAT impairs spatial but not visual learning in a water maze by stimulating 5-HT1A receptors in the hippocampus. Behav Brain Res. 67:1995;67-74.
16. Cassel J.C., Jeltsch H. Serotonergic modulation of cholinergic function in the central nervous system: cognitive implications. Neurosci. 69:1995;1-41.
17. Clemett D.A., Cockett M.I., Marsden C.A., Fone K.C.F. Antisense oligonucleotide-induced reduction in 5-hydroxytryptamine (7) receptors in the rat hypothalamus without alterations in exploratory behavior or neuroendocrine function. J Neurochem. 71:1998;1271-1279.
18. Cohen C., Perrault G.H., Claustre Y., Curet O., Griebel G., Depoortere R., Lourdelet J., Depoortere H., Schoemaker H. Pharmacological characterization of the selective 5-HT1A receptor inverse agonist, SL88.0338-08. Soc Neurosci Abstr. 24:1998;1364.
19. Cole B.J., Jones G.H., Turner J.D. 5-HT1A receptor agonists improve the performance of normal and scopolamine-impaired rats in an operant delayed matching to position task. Psychopharmacology. 116:1994;135-142.
20. Costall B., Naylor R.J. Neuropharmacology of 5-HT3 receptors ligands. Baumgarten H.G., Gother M. Serotoninergic neurons and 5-HT receptors in the CNS. 1997;409-438 Springer, Berlin.
21. Cushing D.J., Zgombick J.M., Nelson D.L., Cohen M.L. LY215840, a high-affinity 5-HT7 receptor ligand, blocks serotonin-induced relaxation in canine coronary artery. J Pharmacol Exp Theor. 277:1996;1560-1566.
22. Datla K.P., Curzon G. Behavioural and neurochemical evidence for the decrease of brain extracellular 5-HT by the antidepressant drug tianeptine. Neuropharmacology. 32:1993;839-845.
23. Deslandes A., Morris R.G.M., Kelley S., Burney D., Anthony T., Spedding M. Tianeptine and its enantiomers: enhanced retention of spatial memory in animals with medial septum lesions. Soc Neurosci Abstr. 24:1998;685.
24. Dickinson A., Squire S., Varga Z., Smith J.W. Omission learning after instrumental pretraining. Quart J Exp Psychol. 51B:1998;271-286.
25. Dijk S.N., Francis P.T., Stratmann G.C., Bowen D.M. NMDA-induced glutamate and aspartate release from rat cortical pyramidal neurones: evidence for modulation by a 5-HT1A antagonist. Br J Pharmacol. 115:1995;1169-1174.
26. Dunnett S.B. Strategies for testing learning and memory abilities in transplanted rats. Dunnett S.D., Björklund A. Functional neural transplantation. 1994;217-251 Raven Press, New York.
27. Duxon M.S., Reavely A.C., Flaningan T.P., Baxter G., Blackburn T.P., Fone K.C.F. Expression of the 5-HT2B receptor protein in the rat brain. Br J Pharmacol. 115:1995;105P.
28. Eglen R.M., Jasper J.R., Chang D.J., Martin G.R. The 5-HT7 receptor: orphan found. TIPS. 18:1997;104-107.
29. Eglen R.M., Wong E.H., Dumuis A., Bockaert J. Central 5-HT4 receptors. TIPS. 16:1995;391-398.
30. File S., Mabbutt P.S. Effects of tianeptine in animal models of anxiety and on learning and memory. Drug Dev Res. 23:1991;47-56.
31. Fillion G., Massot O., Rousselle J.C., Fillion M.P., Prudhomme N. 5-HT-moduline, an endogenous peptide modulating serotoninergic activity via a direct interaction at 5-HT1B/1D receptors. Baumgarten H.G., Gother M. Serotoninergic neurons and 5-HT receptors in the CNS. 1997;293-306 Springer, Berlin.
32. Fletcher A., Forster E.A., Bill D.J., Brown G., Cliffe I.A., Hartley J.E., Jones D.E., et al. : Electrophysiological, biochemical, neurohormonal and behavioral studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonists. Behav Brain Res. 73:1996;337-353.
33. Fletcher S., Barnes N.M. Desperately seeking subunits: are native 5-HT3 receptors really homomeric complexes. TIPS. 19:1998;212-215.
34. Flood J.F., Farr S.A., Uezu K., Morley J.E. The pharmacology of post-trial memory processing in septum. Eur J Pharmacol. 350:1998;31-38.
35. Francis P.T., Pangalos M.N., Pearson R.C.A., Middlemiss D.N., Stratmann G.C., Bowen D.M. 5-Hydroxytryptamine1A but not 5-hydroxytryptamine2 receptors are enriched on neocortical pyramidal neurones destroyed by intrastriatal volkensin. J Pharmacol Exp Theor. 261:1992;1273-1281.
36. Galeotti N., Ghelardini C., Bartolini A. Role of 5-HT4 receptors in the mouse passive avoidance test. J Pharmacol Exp Theor. 286:1998;1115-1121.
37. 4 agonists: BIMU1 and BIMU8 on the social learning test in rats. 1993;CINP Congress, Washington, D.C. June 27-July 1.
38. Ghelardini C, Meoni P, Galeotti N, Malmberg-Aiello O, Rizzi CA, Bartolini A. Effect of the two benzimidazolone derivates: BIMU-1 and BIMU-8 on a model of hypoxia-induced amnesia in the mouse. 5-HT Third IUPHAR Satellite Meeting on Serotonin. Chicago, IL. 30 July-3 August, 1994.
39. Ghelardini C, Malmberg-Aiello O, Bartolini A, Rizzi CA. Protective effect of BIMU-1 and BIMU-8 on amnesia induced by hypercapnia. 10th Congress of European Society of Neurochemistry. Jerusalem. 14-19 August, 1994.
40. Glennon R.A., Dukat M. Serotonin receptor subtypes. Bloom F.E., Kupfer D.J. Psychopharmacology: the fourth generation of progress. 1995;415-429 Raven Press, New York.
41. Gower A.J. 5-HT receptors and cognitive function. Marsden C.A., Heal D.J. Central serotonin receptors and psychotropic drugs. 1992;239-259 Blackwell Scientific Publications, Oxford.
42. Göthert M., Schlicker E. Regulation of 5-HT release in the CNS by presynaptic 5-HT autoreceptors and by 5-HT heteroreceptors. Baumgarten H.G., Göthert M. Serotoninergic neurons and 5-HT receptors in the CNS. 1997;307-350 Springer, Berlin.
43. Griebel G., Cohen C., Perrault G.H., Sanger D.J., Sevrin M., George P., Scatton B. Evaluation of antidepressant- and anxiolytic-like properties of the selective 5-HT1A receptor inverse agonist SL88.0338-08. Soc Neurosci Abstr. 24:1998;1363.
44. Harder J.A., Kelley M.E., Cheng C.H.K., Costall B. Combined PCPA and muscarinic antagonist treatment produces a deficit in rat water maze acquisition. Pharmacol Biochem Behav. 55:1996;61-65.
45. Harder J.A., Maclean C.J., Alder J.T., Francis P.T., Ridley R.M. The 5-HT1A antagonist WAY100635, ameliorates the cognitive impairment induced by fornix transection in the marmoset. Psychopharmacology. 127:1996;245-254.
46. Harvey J.A. Serotonergic regulation of associate learning. Behav Brain Res. 73:1996;47-50.
47. Hasbroucq T., Rihet P., Blin O., Possamai C.A. Serotonin and human information processing: fluoxamine can improve reaction time performance. Neurosci Lett. 229:1997;204-208.
48. Hen R. 5-HT1A and 5-HT5A receptor knockouts: behavioral consequences The fourth IUPHAR Satellite Meeting on Serotonin. 26:1998;. Rotterdam, 23-25 July.
49. Helsley S., Siegel T.L., Fiorella D., Rabin R.A., Winter J.C. WAY-100635 reverses 8-OH-DPAT-induced performance impairment in the radial maze. Prog Neuro-Psychopharmacol Biol Psychiat. 22:1998;1179-1184.
50. Hodges H., Sowinski P., Turner J.J., Fletcher A. Comparison of the effects of the 5-HT3 antagonists WAY-100579 and ondansetron on spatial learning in the water maze in rats with excitotoxic lesions of the forebrain cholinergic projection system. Psychopharmacology. 125:1996;146-161.
51. Hong E., Meneses A. Systemic injection of p-chloroamphetamine eliminates the effect of the 5-HT3 compounds on learning. Pharmacol Biochem Behav. 53:1996;765-769.
52. Hong E., Meneses A., Fillion G. Effect of 5-HT-moduline, an endogenous peptide in associative learning. Proc West Pharmacol Soc. 42:1999.
53. Hoyer D., Hartig P.R., Humphrey P.P.A. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev. 46:1994;157-203.
54. Hoyer D., Martin G.R. Classification and nomenclature of 5-HT receptors: a comment on current issues. Behav Brain Res. 73:1996;263-268.
55. Introinin-Collison I.B., To S., McGaugh J.L. Fluoxetine effects on retention of inhibitory avoidance: enhancement by systemic but not intra-amygdala injections. Psychobiology. 20:1992;28-32.
56. Izquierdo I., Medina J.H., Izquierdo L.A., Barros D.M., Desouza M.M., Souza T.M.E. Short- and long-term memory are differentially regulated by monoaminergic systems in the rat brain. Neurobiol Learn Mem. 63:1998;219-224.
57. Jacobs B.L., Azmitia E.C. Structure and function of the brain serotonin system. Physiol Rev. 72:1992;165-229.
58. Johnson M.P., Siegel B.W., Carr A.A. [3H]MDL 100,907: a novel selective 5-HT2A-receptor ligand. Naunyn-Schmiedeberg's Arch Pharmacol. 354:1996;209.
59. Kant J.G., Meininger G.R., Maughan K.R., Wright W.L., Robinson T.N., Neely T.M. Effects of the serotonin receptor agonists 8-OH-DPAT and TFMPP on learning as assessed using a novel water maze. Pharmacol Biochem Behav. 53:1996;385-390.
60. Kant J.G., Wyle R.M., Chu K., Ghosh S. Effects of the serotonin receptor agonists 8-OH-DPAT, buspirone, and DOI on water maze performance. Pharmacol Biochem Behav. 59:1998;729-735.
61. Keck B.J., Maines L.W., Lakoski J.M. Region and age-dependent diversity in 5-HT1A receptor binding and recovery: comparison with receptor-effector mechanisms. Naunyn-Schmiedeber's Arch Pharmacol. 358:1998;R109. Suppl 1.
62. Kehne J.H., Baron B.M., Carr A.A., Chaney S.F., Elands J., Feldman D.J., Frank R.A., VanGiersbergen P.L.M., McClosky T.C., Johnson M.P., McCarthy D.R., Poirot M., Senyah Y., Siegel B.W., Widmaier C. Preclinical characterization of the potential of the putative atypical antipsychotic MDL 100,907 as a potent 5-HT2A antagonist with a favorable CNS safety profile. J Pharmacol Exp Theor. 277:1996;968-981.
63. Kennett G.A. 5-HT1C receptors and their therapeutic relevance. Curr Opin Invest Drugs. 2:1993;317-362.
64. Kennett G.A., Wood M.D., Glen A., Grewal S., Forbes I., Gadre A., Blackburn T.P. In vivo properties of SB 200646A, a 5-HT2C/2B receptor antagonist. Br J Pharmacol. 111:1994;797-802.
65. Kia H.K., Brisorgueil M.J., Daval, Langlois X., Hamon M., Vergé D. Serotonin1A receptors are expressed by a subpopulation of cholinergic neurons in the rat medial septum and diagonal band of Broca-a double immunocytochemical study. Neuroscience. 74:1996;143-154.
66. Knott P.J., Haroutunian V., McBorrough E.M., Yang R.K., Davidson M., Harvey P., Mohs R., McCrystal J., Davis K.L. Cognitive-impairment in schizophrenia and Alzheimer's disease correlates with citalopram binding in the cerebral cortex The Fourth IUPHAR Satellite Meeting on Serotonin. 106:1998;. Rotterdam, 23-25 July.
67. Koshikawa K., Kitamura M., Tomiyama K., Stephenson J.D. Chronic treatment with tianeptine attenuates the behavioral effects induced by 5-HTP, but not the effects on hippocampal 5-HT concentrations. Neurosci Res Commun. 22:1998;107-116.
68. Letty S., Child A., Dumuis A., Pantaloni A., Bockaert J., Rondouin G. 5-HT4 receptors improve social olfactory memory in the rat. Neuropharmacology. 36:1997;681-687.
69. Liang K.C. Posttraining intra-amygdala of 5-HT1A agonists or antagonists affected memory an inhibitory avoidance task. Soc Neurosci Abstr. 24:1998;2123.
70. Liang X., Arvanov V.L., Wang R.Y. Inhibition of NMDA-receptor mediated response in the rat medial prefrontal cortical pyramidal cells by the 5-HT3 receptor agonist SR 57227 and 5-HT: intracellular studies. Synapse. 29:1998;257-268.
71. Maines L.W., Keck B.J., Polvarapu R., Lakoski J.M. Corticosterone regulation of serotonin1A receptors with aging: GI protein expression and coupling. Naunyn-Schmiedeber's Arch Pharmacol. 358:1998;R109. Suppl 1.
72. Marchetti-Gauthier E., Roman F.S., Dumuis A., Bockaert J., Soumireu-Mourat B. BIMU1 increases associative memory in rats by activating 5-HT4 receptors. Neuropharmacology. 36:1997;697-706.
73. Marrosu F., Fornal C.A., Metzler C.W., Jacobs B.L. 5-HT1A agonists induced hippocampal theta activity in freely moving cats: role of presynaptic 5-HT1A receptors. Brain Res. 739:1996;192-200.
74. Martin G.R., Eglen R.M., Hamblin M.W., Hoyer D., Yocca F. The structure and signaling properties of 5-HT receptors: and endless diversity? TIPS. 19:1998;2-4.
75. Mazer C., Muneyyirci J., Taheny K., Raio N., Borella A., Whitaker-Azmitia P. Serotonin depletion during synaptogenesis leads to decreased synaptic density and learning deficits in the adult brain: a possible model of neurodevelopmental disorders with cognitive deficits. Brain Res. 760:1997;68-73.
76. McGaugh J.L. Dissociating learning and performance: drug and hormone enhancement of memory storage. Brain Res Bull. 23:1989;339-345.
77. Meltzer C.C., Smith G., Dekosky S.T., Pollock B.G., Mathis C.A., Moore R.Y., Kupfer D.J., Reynolds C.F. Serotonin in aging, late-life depression and Alzheimer's disease: the emerging role of functional imaging. Neuropsychopharmacology. 18:1998;407-430.
78. Meneses A. 5-HT receptors as targets for drugs in the treatment of learning and memory dysfunctions. Curr Res Serotonin. 3:1998;214-235.
79. Meneses A. Physiological, pathophysiological and therapeutic roles of 5-HT systems in learning and memory. Rev Neurosci. 9:1998;1-13.
80. Meneses A. Are 5-HT1B/1D and 5-HT2A/2B/2C receptors involved in learning and memory processes? Curr Res Serotonin. 2:1999;796-801.
81. Meneses A., Hong E. Effect of fluoxetine on learning and memory involve multiple 5-HT systems. Pharmacol Biochem Behav. 52:1995;341-346.
82. Meneses A., Hong E. Effects of 5-HT4 receptor agonists and antagonists in learning. Pharmacol Biochem Behav. 56:1997;347-351.
83. Meneses A., Hong E. A pharmacological analysis of serotonergic receptors: effects of their activation or blockade in learning. Prog Neuro-Psychopharmacol Biol Psychiat. 21:1997;273-296.
84. Meneses A., Hong E. Role of 5-HT1A receptors in acquisition, consolidation and retrieval of learning. CNS Drug Rev. 3:1997;68-82.
85. Meneses A., Hong E. Role of 5-HT1B, 5-HT2A and 5-HT2C receptors in learning. Behav Brain Res. 87:1997;105-110.
86. Meneses A., Hong E. Spontaneous hypertensive rat: a potential model to identify drugs for treatment of learning disorders. Hypertension. 31:1998;968-972.
87. Meneses A., Hong E. 5-HT1A receptors modulate the consolidation of learning in normal and cognitively impaired rats. Neurobiol Learn Mem. 71:1999;207-218.
88. Meneses A., Terron J.A., Hong E. Effects of 5-HT receptor antagonists GR127935T (5-HT1B/1D) and MDL 100,907 (5-HT2A) in the consolidation of learning. Behav Brain Res. 89:1997;217-223.
89. Meneses A., Orozco G., Hong E. Effect of 5-HT receptor antagonists SB200646 (5-HT2A/2B/2C) and LY215840 (5-HT7) on learning. Soc Neurosci Abstr. 24:1998;1371.
90. Misane I., Johansson C., Ogren S.O. Analysis of the 5-HT1A receptor involvement in passive avoidance in the rat. Br J Pharmacol. 125:1998;499-509.
91. Molodtsova G.F., Ilyuchenok R.Y. The pre- and postsynaptic mechanisms of the involvement of the serotonin of the amygdaloid body in the reproduction of the conditioned passive avoidance reaction in rats. Zh Vyssh Nerv Deiat Im I P Pavlova. 48:1998;464-470.
92. Moser P.C., Mora P.M., Frank R.A., Kehne J.K. Reversal of amphetamine-induced-behaviors by MDL 100,907, a selective 5-HT2A antagonist. Behav Brain Res. 73:1996;163-167.
93. Nabeshima T.K., Itoh K., Kawashima K., Kameyama T. Effects of 5-HT2 receptor antagonist on cycloheximide-induced amnesia in mice. Pharmacol Biochem Behav. 32:1989;787-790.
94. Nakai K., Fujii T., Fujimoto K., Suzuki T., Kawashima K. Effect of WAY-100635 on the hippocampal acetylcholine release potentiated by 8-OH-DPAT, a serotonin1A receptor agonist, in normal and p-chlorophenylalanine-treated rats as measured by in vivo microdialysis. Neurosci Res. 31:1998;23-29.
95. Newman-Tancredi A., Gavaudan S., Conte C., Chaput C., Touzard M., Verriele L., Aidinot V., Millan M. Agonist and antagonist actions of antipsychotic agents at 5-HT1A receptors: a [35S]GTPγS binding study. Eur J Pharmacol. 355:1998;245-256.
96. Noda Y., Ochi Y., Shimada E., Oka M. Involvement of central cholinergic mechanism in RU-24969-induced behavioral deficits. Pharmacol Biochem Behav. 38:1991;441-446.
97. Nyakas C., Oosterink B.J., Keijser J., Felszeghy J., de Jong G.I., Korf J., Luiten P.G.M. Selective decline of 5-HT1A receptor binding sites in rat cortex, hippocampus and cholinergic basal forebrain nuclei during aging. J Chem Neuroanat. 13:1997;53-61.
98. O'Connor J.J., Rowan M.J., Anwyl R. Actions of 5-HT1 ligands on excitatory synaptic transmission in the hippocampus of alert rats. Br J Pharmacol. 101:1990;171-177.
99. O'Dowd B.S., Zhao W.Q., Ng K.T., Robinson S.R. Chicks injected with antisera to either S-100α or S-100 protein develops amnesia for a passive avoidance task. Neurobiol Learn Mem. 67:1997;197-206.
100. Passani M.B., Corradetti R. Therapeutic potentials of itasetron (DAU6215), a novel 5-HT3 receptor antagonist, in the treatment of central nervous system disorders. CNS Drug Rev. 2:1996;195-213.
101. Pauwels P. 5-HT1B/1D receptor antagonists. Gen Pharmacol. 29:1997;293-303.
102. Pineyro G., DeMontigny C., Bleir P. 5-HT1D receptors regulate 5-HT release in the rat raphe nuclei. Neuropharmacology. 13:1995;249-260.
103. Pineyro G., DeMontigny C., Weiss M., Bleir P. Autoregulatory properties of dorsal 5-HT neurons: possible role of electrotonic coupling and 5-HT1D receptors in the rat brain. Synapse. 22:1996;54-62.
104. Pitsikas N., Borsini F. Different effects of tropisetron and ondansetron in learning and memory paradigms. Pharmacol Biochem Behav. 56:1997;571-576.
105. Pitsikas N., Borsini F. Itasetron (DAU 6215) prevents age-related memory deficits in the rat in multiple choice avoidance task. Eur J Pharmacol. 311:1996;115-119.
106. Pompeiano M., Palacios J.M., Mengod G. Distribution of the serotonin 5-HT2 receptor family mRNA: comparison between 5-HT2A and 5-HT2C receptors. Mol Brain Res. 23:1994;163-178.
107. Ramirez M.J., Cenarruzabeitia E., Lasheras B., Del Rio J. Involvement of GABA systems in acetylcholine release induced by 5-HT3 receptor blockade in slices from rat entorhinal cortex. Brain Res. 712:1996;274-280.
108. Riekkinen M., Sirvio J., Toivanen T., Riekkinen P. Combined treatment with 5-HT1A receptor agonist and muscarinic acetylcholine receptor antagonist disrupts water maze navigation behavior. Psychopharmacology. 122:1995;137-146.
109. Ross S.B., Rényi L., Kelder D. N-methyl-D-aspartate receptor antagonist counteracts the long lasting 5-HT1A receptor-induced attenuation of postsynaptic responses in the rat in vivo. Naunyn-Schmieberg's Arch Pharmacol. 346:1992;138-143.
110. Ruotsalainen S., MacDonald E., Koivisto E., Stefanski R., Haapalinna A., Riekkinen P., Sirvio J. 5-HT1A receptor agonist (8-OH-DPAT) and 5-HT2 receptor agonist (DOI) disrupt the non-cognitive performance of rats in a working memory. J Psychopharmacol. 12:1998;177-185.
111. Ruotsalainen S., Miettinen R., Macdonald E., Riekkinen M., Sirvio J. The role of the dorsal raphe-serotonergic system and cholinergic receptors in the modulation of working memory. Neurosci Biobehav Rev. 22:1998;21-31.
112. Samanin R., Luschi R., Vezzani A., Carli M. Impairment of spatial learning induced by intra-hippocampal scopolamine: its reversal by arecoline, ondansetron and intrahippocampal (+)-WAY 100135. Soc Neurosci Abstr. 20:1994;149.
113. Santucci A.C., Knott P.J., Haroutunian V. Excessive serotonin release, not depletion, leads to memory impairments in rats. Eur J Pharmacol. 295:1996;7-17.
114. Sirviö J., Riekkinen P., Jäkälä P., Riekkinen P.J. Experimental studies on the role of serotonin in cognition. Prog Neurobiol. 43:1994;363-379.
115. Sleight A.J., Boess F.G., Bourson A., Sibley D.R., Monsma F.J. 5-HT6 and 5-HT7 receptors: molecular biology, functional correlates and possible therapeutic indications. Drug News Persp. 10:1997;214-224.
116. Sleight A.J., Boess F.G., Bos M., Levet-Trafit B., Riemer C., Bourson A. Characterization of Ro 04-6790 and Ro 63-0563 selective antagonists at human and rat 5-HT6 receptors. Br J Pharmacol. 124:1997;556-562.
117. Solodkin A., van Hoesen G.W. Neuropathology and functional anatomy of Alzheimer's disease. Brioni J.D., Decker M.W. Pharmacological treatment of Alzheimer's disease. 1997;151-177 Wiley-Liss, New York.
118. Spedding M., Deslandes A., Netzer R., Roeper J., Szabo G., Egyed A. Potentiation of CA1 by the atypical antidepressant Tianeptine. Soc Neurosci Abstr. 24:1998;685.
119. Stanhope K.J., McLenachan A.P., Dourish C.T. Dissociation between cognitive and motor/motivational deficits in the delayed matching to position test: effects of scopolamine 8-OH-DPAT and EAA antagonists. Psychopharmacology. 122:1995;268-280.
120. Staubli U., Xu F.B. Effects of 5-HT3 receptor antagonism on hippocampal theta rhythm, memory, and LTP induction in the freely moving rat. J Neurosci. 15:1995;2445-2452.
121. Steckler T., Sahgal A. The role of serotonergic-cholinergic interactions in the mediation of cognitive behavior. Behav Brain Res. 67:1995;165-199.
122. Stowe R.I., Barnes N.M. Pharmacological characterization and cellular distribution of 5-HT7 receptors in rat brain. Naunyn-Schmiedeber's Arch Pharmacol. 358:1998;R108. Suppl 1.
123. 6 receptor null mutant mice The Fourth IUPHAR Satellite Meeting on Serotonin. 1998;. Rotterdam, 23-25 July.
124. Terry A.V., Buccafusco J.J., Jackson W.J., Prendergast M.A., Fontana D.J., Wong E.H., Bonhaus D.W., Weller P., Eglen R.M. Enhanced delayed matching performance in younger and older macaques administered the 5-HT4 receptor agonist RS 17017. Psychopharmacology. 135:1998;407-415.
125. Tomie A., Cuhna C., Mosakowski E.M., Quartarolo N.M., Pohorecky L.A., Benjamin D. Effects of ethanol on pavlovian autoshaping in rats. Psychopharmacology. 139:1998;154-159.
126. Vanover K.E., Barrett J.E. An automated learning and memory model in mice: pharmacological and behavioral evaluation of an autoshaped responses. Behav Pharmacol. 9:1998;273-283.
127. Warburton E.C., Harrison A.A., Robbins T.W., Everitt B.J. Contrasting effects of systemic and intracerebral infusions of the 5-HT1A receptor agonist 8-OH-DPAT on spatial short-term working memory in rats. Behav Brain Res. 84:1997;247-258.
128. Waszczak B.L., Martin L.P., Jackson D.M. Inhibition of dorsal raphe cells firing by putative 5-HT1A antagonists: 5-HT1A partial agonism or α-adrenergic blockade? Soc Neurosci Abstract. 22:1996;1322.
129. Welsh S.E., Kachelries W.J., Romano A.G., Simansky K.J., Harvey J.A. Effects of LSD, ritanserin, 8-OH-DPAT, and lisuride on classical conditioning in the rabbit. Pharmacol Biochem Behav. 59:1998;469-475.
130. Welsh S.E., Romano A.G., Harvey J.A. Effects of serotonin 5-HT2A/2C antagonists on associative learning in the rabbit. Psychopharmacology. 137:1998;157-163.
131. Whitaker-Azmitia P.M., Azmitia E.C. Astroglial 5-HT1A receptors and S-100 in development and plasticity. Persp Dev Neurobiol. 2:1994;233-238.
132. Wright D.E., Seroogy K.B., Lundgren K.H., Davis B.M., Jennes L. Comparative localization of serotonin1A, 1C and 2 receptor subtype mRNAs in rat brain. J Comp Neurol. 351:1995;357-373.
133. Yu H., Hoo B.B., Hacksell U., Lewander T. The (S)-UH-301induced inhibition of a rat brain serotonin and dopamine synthesis do not seem to be mediated by 5-HT1A receptors. Soc Neurosci Abstr. 22:1996;1327.
134. Zifa E., Fillion G. 5-Hydroxytryptamine receptors. Pharmacol Rev. 44:1992;401-458.
135. Zola-Morgan S., Squire L.R. Neuroanatomy of memory. Ann Rev Neurosci. 168:1993;547-563.
136. Gaster L.M., Blaney F.E., Davies S., et al. The selective 5-HT1B receptor inverse agonist 1(-methyl-5-[[2(-methyl-4(-(5-methyl-1.1.2,4-oxadiazol-3-yl)biphenyl-4-yl] carbonyl]-2,3,6,7-tetrahydrospiro[furo[2,3-f]indole-3,4(-piperidine] (SB-224289) potently blocks terminal 5-HT autoreceptor function both in vitro and in vivo. J Med Chem. 41:1998;1218-1235.
137. Kikuchi C., Nagaso H., Hiranuma T., Koyama M. Tetrahydrobenzindoles: Selective antagonists of the 5-HT7 receptor. J Med Chem. 42:1999;533-535.
138. Balleine B.W., Fletcher N., Dickinson A. Effect of the agonist 8-OH-DPAT on instrumental performance in rats. Psychopharmacology. 125:1996;79-88.
139. Bass E.W., Means L.W., McMillen B.A. Buspirone impairs performance of a three-choice working memory water escape task in rats. Brain Res Bull. 28:1992;455-461.
140. Deacon R.M.J. Pharmacological studies of a rat spatial delayed nonmatch-to-sample task as an animal model of dementia. Drug Dev Res. 24:1991;67-79.
141. Evenden J.L., Angeby K. Effects of 8-hydroxy-2-(di-n-propylaminotetralin (8-OH-DPAT) on locomotor activity and rearing of mice and rats. Psychopharmacology. 102:1990;485-491.
142. Herremans A.H.J., Hijzen T.H., Olivier B., Slangen J.L. Serotonergic drugs effects on a delayed conditional discrimination task in the rat: involvement of the 5-HT1A receptor in working memory. J Psychopharmacol. 9:1995;242-250.
143. Jansen J.H.M., Andrews J.S. The effects of serotonergic drugs on short-term spatial memory in rats. J Psychopharmacol. 8:1994;157-163.
144. Klint T. Effects of 8-OH-DPAT and buspirone in a passive avoidance test and in the elevated plus-maze test in rats. Behav Pharmacol. 2:1991;481-489.
145. Mendelson S.D., Quartermain D., Francisco T., Sherrer A. 5-HT1A receptor agonists induce anterograde amnesia in mice. Eur J Pharmacol. 236:1993;177-182.
146. Meneses A., Hong E. Effects of serotonergic compounds on associative learning. Proc West Pharmacol Soc. 34:1991;461-464.
147. Meneses A., Hong E. Modification of 8-OH-DPAT effect on learning by manipulation of the assay conditions. Behav Neural Biol. 61:1994;29-35.
148. Meneses A., Hong E. Mechanisms of action of 8-OH-DPAT on learning and memory. Pharmacol Biochem Behav. 49:1994;1083-1086.
149. Quatermain D., Clemente J., Shemer A. The 5-HT1A agonist tandospirone disrupts retention but not acquisition of active avoidance learning. Pharmacol Biochem Behav. 48:1994;805-807.
150. Riekkinen P. 5-HT1A and muscarinic acetylcholine receptors jointly regulate passive avoidance behavior. Eur J Pharmacol. 262:1994;77-90.
151. Rowan M.J., Cullen W.K., Moulton B. Buspirone impairment of performance of passive avoidance and spatial learning tasks in the rat. Psychopharmacology. 100:1990;393-398.
152. Sanger D.J., Joly D. Performance of a passive avoidance response is disrupted by compounds acting at 5-HT1A receptors. Behav Pharmacol. 1:1989;235-240.
153. Sanger D.J., Joly D., LePichon M. Buspirone, gepirone and ipsapirone disrupt both active and passive avoidance responding in rats. Behav Pharmacol. 1:1989;153-160.
154. Sarter M. Taking stock of cognition enhancers. TIPS. 112:1991;456-461.
155. Torres C., Morales A., Cándido A., Maldonado A. Differential effect of buspirone and diazepam on negative contrast in one-way avoidance learning. Eur J Pharmacol. 280:1995;277-284.
156. Traber J., Davies M.A., Dompert W.U., Glaser T., Schuurman T., Seidel P.R. Brain serotonin receptors as a target for the putative anxiolytic TVX Q 7821. Brain Res Bull. 12:1984;741-744.
157. Unrug-Neervoort A., VanLuijtelaar G., Coenen A. Cognition and vigilance; differential effects of diazepam and buspirone on memory and psychomotor performance. Neuropsychobiology. 26:1992;146-150.
158. Winsauer P.J., Bixler M.A., Mele P.C. Comparison of the effects of typical and atypical anxiolytics on learning in monkeys and rats. J Pharmacol Exp Theor. 276:1996;1111-1127.
159. Winter J.C., Petti D.T. The effects of 8-hydroxy-2-(di-n-propylamino)tetralin and other serotonergic agonists on performance in a radial maze: A possible role for 5-HT1A receptors in memory. Pharmacol Biochem Behav. 27:1987;625-628.
160. Mora P.O., Netto C.F., Graeff F.G. Role of 5-HT2A and 5-HT2C receptors subtypes in the two types of fear generated by elevated T-maze. Pharmacol Biochem Behav. 58:1997;1051-1057.
161. 1B agonists in the rat 5-HT Third IUPHAR Satellite Meeting on Serotonin. 1994;58. 30 July-August 3, Chicago, IL.
162. Ruotsalainen S., Sirvio J., Jakala P., Puumala T., MacDonald E., Riekkinen P. Differential effects of three 5-HT receptor antagonists on the performance of rats in attentional and working memory tasks. Eur. Neuropsycholpharmacol. 7:1997;99-108.
163. Stephenson R.M., Andrew R.J. The effects of 5-HT receptor blockade on memory formation in chick: possible interactions between β-adrenergic, and serotonergic systems. Pharmacol Biochem Behav. 48:1994;971-975.
164. Riekkinen M., Sirvio J., Riekkinen P. Treatment with 5-HT2A/2C receptor agonist disrupts initial development of spatial navigation strategies in rats. Soc Neurosci Abstr. 20:1994;1546.
165. Flood J.F., Farr, Uezu K., Morley J.E. Aged-related changes in septal serotonergic, GABAergic and glutamatergic facilitation of retention in SAMP8 mice. Mech Ageing Dev. 105:1998;173-188.
166. Helsley S., Siegel T.L., Fiorella D., Rabin R.A., Winter J.C. WAY-100635 reverses 8-OH-DPAT-induced performance impairment in the radial maze. Prog Neuropsychopharmacol Biol Psychiat. 22:1998;1179-1184.
167. Misane I., Johansson C., Ogren S.O. Analysis of the 5-HT1A receptor involvement in passive avoidance in the rat. Br J Pharmacol. 125:1998;499-509.
168. Carli M., Bonalumi P., Samanin R. Stimulation of 5-HT1A receptors in the dorsal raphe reverses the impairment caused by intrahippocampal scopolamine in rats. Eur J Neurosci. 10:1998;221-230.
169. Winsauer P.J., Rodriguez F.H., Cha A.E., Moerschbaecher J.M. Full and partial 5-HT1A receptor agonists disrupt learning and performance in rats. J Pharmacol Exp Theor. 288:1999;335-347.
170. Porsolt R.D., Roux S., Wettstein J.G. Animal studies of dementia. Drug Dev Res. 35:1995;214-229.
171. Smith J.E., Lakoski J.M. Electrophysiological study of the effects of the reuptake inhibitor duloxetine on serotonergic responses in the aging hippocampus. Pharmacology. 55:1997;66-77.
172. Arnsten A.F.T., Lin C.H., Van Dick C.H., Stanhope K.J. The effects of 5-HT3 receptor antagonists on cognition performance in aged monkeys. Neurobiol Aging. 18:1997;21-28.
173. Buhot M.C., Naili S. Changes in exploratory activity following stimulation -HT1A and 5-HT1B receptors in the rat. Hippocampus. 5:1995;198-208.
174. Marek G.J., Aghajanian G.A. The electrophysiology of prefrontal serotonin systems: therapeutic implications for mood and psychosis. Biol Psychiat. 44:1998;1118-1127.
175. Meneses A. 5-HT systems as targets for the treatment of learning and memory dysfunctions. Soc Neurosci Abstr. 25:1999;174.
176. Davis P.A., Pistis M., Hanna M.C., et al. The 5-HT3B subunit is a major determinant of serotonin-receptor function. Nature. 397:1999;359-363.
177. Teccott L.H., Logue S.F., Wehner J.M., Kauer J.A. Perturbed dentate gyrus
178. DeLong G.R., Teague L.A., Kamran M.M. Effects of fluoxetine treatment in young children with idiopathic autism. Dev Med Child Neurol. 40:1998;551-562.
179. Õgren S.O., Misane I. Animals models for studying serotonin (5-HT) receptor subtypes: relationship to 5-HT system pathologies. Nucl Med Biol. 25:1998;747-749.
180. Morgan M.J. Memory deficits associated with recreational use of ecstasy. Psychopharmacology. 141:1999;30-36.
181. Malleret G., Hen R., Guillou J.L., Segu L., Buhot M.C. 5-HT1B receptor knock-out mice exhibit increased exploratory activity and enhanced spatial memory performance in the Morris water maze. J Neurosci. 19:1999;6157-6168.
182. 4 receptors in the brain and periphery. Eglen R.M. 1998;103-126 Springer, Berlin.
183. 4 receptors in the brain and the periphery. 1998;63-86.
184. Claeysen S., Sebben M., Becamel C., Bockaert J., Dumuis A. Novel brain-specific 5-HT4 receptor splice variants show marked constitutive activity: role of the C-terminal intracellular domain. Mol Pharmacol. 55:1999;910-920.
185. Coizet V., Lehmann O., Kelche C., Cassel C. Effects of 8-OH-DPAT or SR 57746A long term treatment combined with muscarinic blockade on spatial memory in the rat. Intl Behav Neurosci Soc Abstr. 1999;43.
186. Roman F., Marchetti E. Involvement of 5-HT receptors in learning and memory. IDrugs. 1:1998;109-121.
187. Yau J.L., Olsson T., Noble J., Seckl J.R. Serotonin receptor subtype gene expression in the hippocampus of aged rats following chronic amitriptyline treatment. Brain Res Mol Brain Res. 70:1999;282-287.
188. Duncan M.J., Short J., Wheeler D.L. Comparison of the effects of aging on 5-HT7 and 5-HT1A receptors in discrete regions of the circadian timing system in hamsters. Brain Res. 829:1999;39-45.